LMO2 confers value as a potential immunotherapy marker in pan-cancer analysis and inhibits progression of Clear Cell Renal Cell Carcinoma
Abstract Full pan-cancer analysis of LMO2 with immunotherapeutic target assessment. ZC3h13 mediated m6A modification controls LMO2 expression in ccRCC. LMO2…